349 related articles for article (PubMed ID: 35504064)
1. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa.
Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
Cancer Epidemiol; 2022 Jun; 78():102167. PubMed ID: 35504064
[TBL] [Abstract][Full Text] [Related]
2. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
[TBL] [Abstract][Full Text] [Related]
3. Facing up to the ongoing challenge of Kaposi's sarcoma.
Robey RC; Bower M
Curr Opin Infect Dis; 2015 Feb; 28(1):31-40. PubMed ID: 25490104
[TBL] [Abstract][Full Text] [Related]
4. Acquired immunodeficiency syndrome-associated cancers in Sub-Saharan Africa.
Thomas JO
Semin Oncol; 2001 Apr; 28(2):198-206. PubMed ID: 11301383
[TBL] [Abstract][Full Text] [Related]
5. AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies.
Martellotta F; Berretta M; Vaccher E; Schioppa O; Zanet E; Tirelli U
Curr HIV Res; 2009 Nov; 7(6):634-8. PubMed ID: 19929800
[TBL] [Abstract][Full Text] [Related]
6. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.
Freeman EE; Busakhala N; Regan S; Asirwa FC; Wenger M; Seth D; Moon KC; Semeere A; Maurer T; Wools-Kaloustian K; Bassett I; Martin J
BMC Cancer; 2020 Jan; 20(1):71. PubMed ID: 31996161
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
9. Variants of Kaposi's sarcoma in Southern Africa. A retrospective analysis (1980-1992).
Stein ME; Lachter J; Spencer D; Margolius L; Bezwoda WR
Acta Oncol; 1996; 35(2):193-9. PubMed ID: 8639315
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma in sub-Saharan Africa: a current perspective.
Mosam A; Aboobaker J; Shaik F
Curr Opin Infect Dis; 2010 Apr; 23(2):119-23. PubMed ID: 19996745
[TBL] [Abstract][Full Text] [Related]
11. Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy.
Dittmer DP
mBio; 2011; 2(6):e00138-11. PubMed ID: 22045987
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
[TBL] [Abstract][Full Text] [Related]
13. Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout.
Motlhale M; Muchengeti M; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Bender N; Mathew CG; Newton R; Waterboer T; Singh E; Sitas F
Int J Cancer; 2023 May; 152(10):2081-2089. PubMed ID: 36727526
[TBL] [Abstract][Full Text] [Related]
14. Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt".
Dollard SC; Butler LM; Jones AM; Mermin JH; Chidzonga M; Chipato T; Shiboski CH; Brander C; Mosam A; Kiepiela P; Hladik W; Martin JN
Int J Cancer; 2010 Nov; 127(10):2395-401. PubMed ID: 20143397
[TBL] [Abstract][Full Text] [Related]
15. Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan Africa.
Freeman E; Semeere A; Wenger M; Bwana M; Asirwa FC; Busakhala N; Oga E; Jedy-Agba E; Kwaghe V; Iregbu K; Jaquet A; Dabis F; Yumo HA; Dusingize JC; Bangsberg D; Anastos K; Phiri S; Bohlius J; Egger M; Yiannoutsos C; Wools-Kaloustian K; Martin J
BMC Cancer; 2016 Feb; 16():65. PubMed ID: 26852390
[TBL] [Abstract][Full Text] [Related]
16. Isolated penile Kaposi's sarcoma in a HIV-positive patient stable on treatment for three years.
Lebari D; Gohil J; Patnaik L; Wasef W
Int J STD AIDS; 2014 Jul; 25(8):607-10. PubMed ID: 24492851
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in HIV-associated Kaposi sarcoma.
Dalla Pria A; Pinato DJ; Bracchi M; Bower M
F1000Res; 2019; 8():. PubMed ID: 31297181
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma.
Friedman-Kien AE; Saltzman BR
J Am Acad Dermatol; 1990 Jun; 22(6 Pt 2):1237-50. PubMed ID: 2193952
[TBL] [Abstract][Full Text] [Related]
19. AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa.
Chu KM; Mahlangeni G; Swannet S; Ford NP; Boulle A; Van Cutsem G
J Int AIDS Soc; 2010 Jul; 13():23. PubMed ID: 20615222
[TBL] [Abstract][Full Text] [Related]
20. Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review.
Rees CA; Keating EM; Lukolyo H; Danysh HE; Scheurer ME; Mehta PS; Lubega J; Slone JS;
Pediatr Blood Cancer; 2016 Aug; 63(8):1325-31. PubMed ID: 27082516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
